Middle East & Africa In-Vitro Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)

No. of Pages: 118    |    Report Code: TIPRE00022124    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa In-Vitro Diagnostics Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Middle East & Africa In-Vitro Diagnostics Market - Key Industry Dynamics

4.1       Key Market Drivers

4.1.1         Increasing Prevalence of Chronic and Infectious Diseases

4.1.2         Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic

4.2       Market Restraint

4.2.1         Insufficiency of Regulatory Frameworks and Reimbursement Policies

4.3       Market Opportunities

4.3.1         Integration of IVD with Digital Health Technologies

4.4       Future Trends

4.4.1         Increasing Demand for Personalized Medicine and Genomics

5.           In-Vitro Diagnostics Market - Middle East & Africa Market Analysis

5.1       Middle East & Africa In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030

6.           Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

6.1       Overview

6.2       Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

6.3       Reagents and Kits

6.3.1         Overview

6.3.2         Reagents and Kits: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

6.4       Software and Services

6.4.1         Overview

6.4.2         Software and Services: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

6.5       Instruments

6.5.1         Overview

6.5.2         Instruments: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.           Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology

7.1       Overview

7.2       Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

7.3       Immunoassay/ Immunochemistry

7.3.1         Overview

7.3.2         Immunoassay/ Immunochemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Clinical Chemistry

7.4.1         Overview

7.4.2         Clinical Chemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.5       Molecular Diagnostics

7.5.1         Overview

7.5.2         Molecular Diagnostics: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.6       Microbiology

7.6.1         Overview

7.6.2         Microbiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Blood Glucose Self-Monitoring

7.7.1         Overview

7.7.2         Blood Glucose Self-Monitoring: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Coagulation and Hemostasis

7.8.1         Overview

7.8.2         Coagulation and Hemostasis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.9       Hematology

7.9.1         Overview

7.9.2         Hematology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.10     Urinalysis

7.10.1       Overview

7.10.2       Urinalysis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.11     Others

7.11.1       Overview

7.11.2       Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application

8.1       Overview

8.2       Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)

8.3       Infectious Disease

8.3.1         Overview

8.3.2         Infectious Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Diabetes

8.4.1         Overview

8.4.2         Diabetes: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       Oncology

8.5.1         Overview

8.5.2         Oncology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       Cardiology

8.6.1         Overview

8.6.2         Cardiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       Autoimmune Diseases

8.7.1         Overview

8.7.2         Autoimmune Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Nephrology

8.8.1         Overview

8.8.2         Nephrology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.9       Others

8.9.1         Overview

8.9.2         Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User

9.1       Overview

9.2       Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

9.3       Hospitals

9.3.1         Overview

9.3.2         Hospitals: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Laboratories

9.4.1         Overview

9.4.2         Laboratories: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Homecare

9.5.1         Overview

9.5.2         Homecare: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.6       Others

9.6.1         Overview

9.6.2         Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1     Middle East & Africa In-Vitro Diagnostics Market

10.1.1       Overview

10.1.2       Middle East & Africa In-Vitro Diagnostics Market, by Country

10.1.2.1          South Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.1.1        Overview

10.1.2.1.2        South Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.1.3        South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.1.4        South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.1.5        South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.1.6        South Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.2          Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.1        Overview

10.1.2.2.2        Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.3        Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.2.4        Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.2.5        Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.2.6        Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.3          UAE: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.1        Overview

10.1.2.3.2        UAE: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.3        UAE: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.3.4        UAE: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.3.5        UAE: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.3.6        UAE: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.4          Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.4.1        Overview

10.1.2.4.2        Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.4.3        Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.4.4        Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.4.5        Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.4.6        Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

11.        Industry Landscape

11.1     Organic Developments

11.1.1       Overview

11.2     Inorganic Developments

11.2.1       Overview

12.        Company Profiles

12.1     Abbott Laboratories

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     F. Hoffmann-La Roche Ltd

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     Danaher Corp

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Siemens AG

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Sysmex Corp

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     Thermo Fisher Scientific Inc

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Becton Dickinson and Co

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     bioMerieux SA

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     Bio-Rad Laboratories Inc

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Qiagen NV

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

13.        Appendix

13.1     About Us

13.2     Glossary of Terms

 

 

 

 

List of Tables

Table 1.             Middle East & Africa In-Vitro Diagnostics Market Segmentation

Table 2.             South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 3.             South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 4.             South Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 5.             South Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 6.             Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 9.             Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 10.          UAE: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 11.          UAE: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 12.          UAE: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 13.          UAE: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 14.          Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 17.          Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 18.          Organic Developments Done by Companies

Table 19.          Inorganic Developments Done by Companies

Table 20.          Glossary of Terms, Middle East & Africa In-Vitro Diagnostics Market

 

 

List of Figures

Figure 1.           Middle East & Africa In-Vitro Diagnostics Market Segmentation, By Country

Figure 2.           Middle East & Africa In-Vitro Diagnostics Market: Key Industry Dynamics

Figure 3.           Middle East & Africa In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 4.           Middle East & Africa In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030

Figure 5.           Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 6.           Reagents and Kits: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Software and Services: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Instruments: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 10.        Immunoassay/ Immunochemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Clinical Chemistry: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Molecular Diagnostics: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Microbiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        Blood Glucose Self-Monitoring: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Coagulation and Hemostasis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Hematology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Urinalysis: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)

Figure 20.        Infectious Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Diabetes: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        Oncology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Cardiology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Autoimmune Diseases: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Nephrology: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        Middle East & Africa In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.        Hospitals: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Laboratories: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Homecare: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Others: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 33.        Middle East & Africa In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)

Figure 34.        South Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 35.        Saudi Arabia: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 36.        UAE: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 37.        Rest of Middle East & Africa: Middle East & Africa In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

 

 

The List of Companies - Middle East & Africa In-Vitro Diagnostics Market

  1. Abbott Laboratories 
  2. F. Hoffmann-La Roche Ltd 
  3. Danaher Corp 
  4. Siemens AG
  5. Sysmex Corp 
  6. Thermo Fisher Scientific Inc 
  7. Becton Dickinson and Co
  8. bioMerieux SA 
  9. Bio-Rad Laboratories Inc
  10. Qiagen NV